BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32503466)

  • 1. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis.
    Xiao G; Yang Q; Bao Z; Mao H; Zhang Y; Lin S
    BMC Cancer; 2020 Jun; 20(1):525. PubMed ID: 32503466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
    Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel Target of Colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion via Activation of CXCR4/NF-κB Signaling.
    Kou T; Sha D; Wang F; He T; He X
    Cell Biochem Biophys; 2021 Mar; 79(1):113-121. PubMed ID: 33151473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
    Wu Y; Chen C; Hua X; Zhao C; Min H
    BMC Cancer; 2024 Apr; 24(1):537. PubMed ID: 38678238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population.
    Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
    Pathol Int; 2021 Jan; 71(1):60-69. PubMed ID: 33159706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between tripartite motif-containing protein 44 protein expression and the prognosis of postoperative patients exhibiting skin squamous cell carcinoma.
    Wu J; Guo NZ; Cui LL; Wang W; Xiong CQ; Zhang XY
    Medicine (Baltimore); 2018 Nov; 97(44):e13021. PubMed ID: 30383661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
    Yang M; Li Y; Tian F
    Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of TRIM44 Expression in Patients with Gastric Cancer.
    Goshayeshi L; Afshar J; Mehrad-Majd H
    Asian Pac J Cancer Prev; 2022 May; 23(5):1725-1731. PubMed ID: 35633558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and clinicopathological significance of CapG in various cancers: Evidence from a meta-analysis.
    Lang Z; Chen Y; Zhu H; Sun Y; Zhang H; Huang J; Zou Z
    Pathol Res Pract; 2019 Dec; 215(12):152683. PubMed ID: 31685300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
    Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
    Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
    Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
    Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44.
    Li W; Chen G; Feng Z; Zhu B; Zhou L; Zhang Y; Mai J; Jiang C; Zeng J
    Genes Genomics; 2021 Dec; 43(12):1413-1421. PubMed ID: 34677810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis.
    Guo J; Min K; Deng L
    Medicine (Baltimore); 2021 Aug; 100(32):e26868. PubMed ID: 34397900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
    Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
    BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
    Li P; Yin H; Meng F; Liu S; Liu H; Ma R
    Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of LINC00673 in human malignancy: a review and meta-analysis.
    Zhu Y; Zhang Z; Peng H; Li W; Hu S; Zhao M; Lin W
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34231850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
    Kawaguchi T; Komatsu S; Ichikawa D; Hirajima S; Nishimura Y; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Tumour Biol; 2017 Jun; 39(6):1010428317700409. PubMed ID: 28618928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
    Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
    Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.